SANTA CLARA, Calif., November 8, 2017 – IP Infusion, a leader in disaggregated networking solutions, announced today that it supports the hardware design of the "Cassini" packet transponder, developed by Edgecore Networks®, the leader in open networking, with other industry partners. Cassini offers a whitebox solution for data center interconnect and service provider use cases, which supports the OcNOS™ disaggregated switching software from IP Infusion.
Edgecore Networks contributed to the hardware design for the Cassini packet transponder for the Open Optical Packet Transport project group in Telecom Infra Project (TIP). Cassini is the industry's highest capacity and first modular whitebox packet transponder to offer a flexible mix of 100 Gigabit Ethernet (GbE) packet switching ports and 100/200 Gbps coherent optical interfaces for metro and long-haul connections.
"With the explosion in data center traffic, enterprises need to interconnect geographically dispersed locations to scale applications and take care of high availability and redundancy demands," said Atsushi Ogata, President and CEO of IP Infusion. "By offering our OcNOS network operating system on Edgecore's Cassini packet transponder, our data center and service provider customers can integrate packet switching and optical transport technology and handle increased demands on their open network, disaggregated networks."
The OcNOS network operating system, combined with the Edgecore platform, extends virtualized services between sites; increases total capacity both inside and between locations; and enhances network resilience. With the ability to adopt cloud-scale economic solutions, enterprises can easily extend and migrate existing metro and long-haul Dense Wavelength Division Multiplexing (DWDM) networks to add new 100G capacities, and extend inter-DC L2 and L3 services.
The Cassini packet transponder is a 1.5RU form factor with system throughput of 3.2Tbps based on Broadcom StrataXGS™ Tomahawk™ Plus switch silicon. The Cassini design offers 16 fixed 100 Gigabit Ethernet QSFP28 ports, plus eight line card slots to incorporate a flexible mix of additional 100GbE ports or ACO/DCO optical ports based on coherent DSP and optical transceivers from leading optical technology partners.
For more information on OcNOS, please see https://www.ipinfusion.com/products/ocnos.
IP Infusion について
IP Infusion is a leading provider of open network software and solutions for carriers, service providers and data center operators with over 500 customers and thousands of deployments. Our solutions enable network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. Northforge Innovations is a registered trademark of Northforge Innovations, Inc. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.
-end-
メディア窓口
Katherine Verducci, 1903 PR, kverducci@1903pr.com, 408.429.5779
IP Infusion について
IP Infusion はオープンネットワーキングソフトウェアの主要プロバイダーであり、サービスプロバイダー、データセンター、AI ファブリックネットワーク向けのキャリアグレードネットワーク OS である OcNOS を提供しています。1999 年以来のネットワーク技術の知見と世界 600+ のオペレーターでの実績により、Edgecore Networks、UfiSpace、Celestica などのパートナーによる検証済みオープンハードウェア上で、オープンかつマルチベンダーで、コスト効率が高く柔軟なネットワークインフラを実現します。IP Infusion はACCESS CO., LTD.（東京証券取引所: 4813）の完全子会社です。
メディア窓口
For press inquiries, analyst briefings, or media materials, please チームへお問い合わせ or email pr@ipinfusion.com.
将来見通しに関する記述
本リリースには、IP Infusion の製品、技術および計画に関する将来見通しの記述が含まれる場合があります。将来見通しに関する記述は公表日時点で入手可能な情報に基づいており、リスクと不確実性を伴います。実際の結果は異なる可能性があります。製品計画、機能、リリース時期および提供状況は予告なく変更されることがあり、確約、約束または法的義務を構成するものではありません。IP Infusion は将来見通しに関する記述を更新する義務を負いません。